| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 122.40B | 129.32B | 119.26B | 111.38B | 94.83B | 70.46B |
| Gross Profit | 23.04B | 24.38B | 22.53B | 20.98B | 17.21B | 12.16B |
| EBITDA | 4.23B | 4.35B | 4.44B | 3.85B | 2.40B | 410.99M |
| Net Income | 2.69B | 2.81B | 2.81B | 3.06B | 1.63B | -114.14M |
Balance Sheet | ||||||
| Total Assets | 37.43B | 41.11B | 37.79B | 35.66B | 33.20B | 27.62B |
| Cash, Cash Equivalents and Short-Term Investments | 6.12B | 7.89B | 6.13B | 3.99B | 4.08B | 3.21B |
| Total Debt | 218.00M | 301.00M | 295.00M | 426.25M | 1.23B | 2.77B |
| Total Liabilities | 22.77B | 24.14B | 23.31B | 22.96B | 22.16B | 18.10B |
| Stockholders Equity | 14.66B | 16.97B | 14.48B | 12.69B | 11.04B | 9.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.20B | 3.23B | 2.67B | 2.54B | 259.59M |
| Operating Cash Flow | 0.00 | 3.27B | 3.74B | 2.81B | 2.58B | 520.14M |
| Investing Cash Flow | 0.00 | -2.98B | -546.00M | -90.07M | 50.27M | 201.53M |
| Financing Cash Flow | 0.00 | -980.00M | -1.08B | -2.82B | -1.77B | -436.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥21.88B | 7.06 | ― | 4.11% | 8.44% | -0.36% | |
64 Neutral | ¥26.84B | 12.47 | ― | 1.94% | 2.71% | 10.31% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ¥14.12B | 5.51 | ― | 3.17% | 5.80% | 1.52% | |
58 Neutral | ¥66.82B | 15.39 | ― | 1.48% | 6.48% | 20.06% | |
57 Neutral | ¥8.59B | 22.91 | ― | 0.95% | 8.07% | 35.89% |